| Financial Year |
March 31 2023 |
| Monetary Funds |
236,102,612.72 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
451,436,097.55 |
| Advances to Suppliers |
303,450,416.42 |
| Other Receivables |
189,467,451.16 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
478,045,971.98 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
47,619.00 |
| Other Current Assets |
28,244,839.64 |
| Total Current Assets |
1,686,795,008.47 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
307,001,758.53 |
| Investment Properties |
-- |
| Fixed Assetes |
1,355,333,014.04 |
| Under-construction Projects |
140,615,103.63 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
348,438,947.51 |
| R&D expenses |
-- |
| Goodwill |
356,794,137.90 |
| Long-Term Deferred and Prepaid Expenses |
3,750,449.21 |
| Deferred Income Tax Assets |
58,776,138.02 |
| Other Non-Current Assets |
406,607,707.22 |
| Sub-Total of Non-Current Assets |
3,011,063,295.38 |
| Total Assets |
4,697,858,303.85 |
| Short-Term Loans |
895,882,283.33 |
| Trading Financial liabilities |
-- |
| Notes Payable |
57,210,000.00 |
| Accounts Payable |
241,007,493.20 |
| Accounts Received In Advance |
1,171,570.38 |
| Employee Compensation Payable |
37,707,583.09 |
| Taxes Payable |
30,676,008.19 |
| Interest Payable |
32,483.38 |
| Dividend Payable |
381,614.44 |
| Other payables |
125,791,996.10 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
372,785,065.49 |
| Other Current Liabilities |
27,015,416.96 |
| Sub-Total of Current Liabilities |
1,811,610,298.70 |
| Long-term Loans |
224,035,143.43 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
7,589,156.91 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
275,463,133.96 |
| Total Liabilities |
2,087,073,432.66 |
| Paid-In Capital(Or Share Stock) |
743,999,550.00 |
| Capital Surplus |
1,567,167,267.01 |
| Surplus Reserve |
36,525,294.91 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
137,794,793.33 |
| Minority Stockholder's Interest |
125,297,965.94 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,485,486,905.25 |
| Owner's Equity（Stockholder's Equity） |
2,610,784,871.19 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
4,697,858,303.85 |
